Tianyi Wang

Tianyi Wang

Auto-generated profile, based on publicly available information

Tianyi Wang

University of Michigan Medical School

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
HKHolly Keane
Holly Keane
YHYash S. Huilgol
Yash S. Huilgol
YSYiwey Shieh
Yiwey Shieh
JTJeffrey A. Tice
Jeffrey A. Tice
JBJeff Belkora
Jeff Belkora
LELaura J. Esserman
Laura J. Esserman
Breast cancer risk reduction has been validated by large-scale clinical trials, but uptake remains low. A risk communication tool could provide personalized risk-reduction information for high-risk women. A low-literacy-friendly, visual, and personalized tool was designed as part of the Women Informed to Screen Depending On Measures of risk (WISDOM) study. The tool integrates genetic, polygenic, and lifestyle factors, and quantifies the risk-reduction from undertaking medication and lifestyle interventions. The development and design process utilized feedback from clinicians, decision-making scientists, software engineers, and patient advocates. We piloted the tool with 17 study participants, collecting quantitative and qualitative feedback. Overall, participants felt they better understood their personalized breast cancer risk, were motivated to reduce their risk, and considered lifestyle interventions. The tool will be used to evaluate whether risk-based screening leads to more informed decisions and higher uptake of risk-reduction interventions among those most likely to benefit.

14 October 2024 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
TWTianyi Wang
Tianyi Wang
MCMandy Che
Mandy Che
YHYash S. Huilgol
Yash S. Huilgol
HKHolly Keane
Holly Keane
DGDeborah Goodman
Deborah Goodman
LELaura J. Esserman
Laura J. Esserman
Breast cancer risk reduction strategies have been well-validated, but barriers remain for high-risk individuals to adopt them. We performed a study among participants with high risk of breast cancer to validate whether a virtual breast health decision tool impacted a participant’s willingness to start risk-reducing activities, identify barriers to adopting these strategies, and understand if it affects breast cancer anxiety. The study sample was 318 participants in the personalized (investigational) arm of the Women Informed to Screen Depending on Measures of risk (WISDOM) clinical trial. After reviewing the tool, these participants completed a feedback survey. We demonstrated that 15 (4.7%) women were taking endocrine risk reduction, 123 (38.7%) were reducing alcohol intake, and 199 (62.6%) were exercising. In the three-month follow-up survey of 109 respondents, only 8 of 61 (13.1%) women who considered endocrine risk reduction pursued it. In contrast, 11 of 16 (68%) participants who considered alcohol reduction pursued the activity, and 14 of 24 (58%) women who considered exercise followed through. Participants listed fear of side effects as the most common barrier to endocrine risk reduction. We also present further steps to be taken to improve the effectiveness of the Breast Health Decisions tool.

29 November 2019 in medRxiv
Verified
Preprint
Open access
PDF file
TWTianyi Wang
Tianyi Wang
TVThanh Le Viet
Thanh Le Viet
TTTung Son Trinh
Tung Son Trinh
HDH Rogier van Doorn
H Rogier van Doorn
CZCharlotte Zheng
Charlotte Zheng
SLSonia Lewycka
Sonia Lewycka
Background: Antibiotic resistance is an important global public health issue, perpetuated by increases in antibiotic use. In low- and middle-income countries (LMICs), tackling antibiotic resistance bacteria is especially challenging. Due to high rates of infectious disease and continuing high mortality from untreated bacterial infections, policy must balance tackling both antibiotic access and antibiotic overuse. This paper investigates the social and health-seeking determinants that impact appropriate and inappropriate antibiotic use in Vietnamese children under 5 for Acute Respiratory Illness (ARI). Methods: Descriptive analyses and logistic regression models were performed on country-wide household data from UNICEF Multiple Indicator Cluster Surveys in 2006, 2011, 2014. Results: Results show that antibiotic overuse is higher in those who sought care from a healthcare provider than those who self-treated. In 2014, children who sought care at private facilities and government facilities were more likely to overuse antibiotics for mild respiratory infections (OR 6.1 and OR 3.8 respectively) than those who did not seek care at private and government facilities respectively. Furthermore, higher socioeconomic level was associated with both appropriate antibiotic use for pneumonia and inappropriate for mild ARI. Children in the poorest households in 2011 and 2014 were less likely to appropriately use antibiotics than those from other socioeconomic levels (OR 0.37 and 0.025 respectively). And children in the poorest households in 2014 were less likely to inappropriately use antibiotics for mild ARI than all other socioeconomic levels (OR 0.36). Conclusions: These findings support, challenge, and broaden current understandings of antibiotic usage in Vietnam. Our results suggest that inappropriate antibiotic use arises from the provider and institutional level. Consequently, we argue that community education efforts and enforcing antibiotics as prescription-only is insufficient. Instead, more focus should be made on reducing financial incentives and infrastructural weaknesses at hospitals and health centres. Furthermore, our results show the need to provide the poorest households with sufficient access to antibiotics. Health policy should tackle the issue of inappropriate use of antibiotics for mild ARI among higher socioeconomic groups.

10 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CZCharlotte Zheng
Charlotte Zheng
AKAbilasha Karkey
Abilasha Karkey
TWTianyi Wang
Tianyi Wang
GMGerald Makuka
Gerald Makuka
HDH Rogier van Doorn
H Rogier van Doorn
SLSonia Lewycka
Sonia Lewycka
Objectives: Our aims were to examine the geographic, socio-economic and behavioural factors associated with disease and antibiotic consumption in Nepal between 2006 and 2016 and to explore healthcare seeking patterns and the source of antibiotics. Methods: Cross-sectional data from children under five in households in Nepal was extracted from the 2006, 2011 and 2016 Demographic Health Surveys (DHS). Univariate and multivariate analyses were carried out to assess the association of disease prevalence and antibiotic use with age, sex, ecological zone, urban/rural location, wealth index, maternal smoking, use of clean fuel, sanitation, nutrition, access to healthcare and vaccinations. Results: Prevalence of fever, acute respiratory infection (ARI) and diarrhoea decreased between 2006 and 2016, while the proportion using antibiotics increased. Wealth, use of clean fuel, improved toilet sanitation, nutrition and access to healthcare were associated with reduced rates of disease. Those in the highest wealth index use less antibiotics and antibiotic consumption in rural areas surpassed urban regions over time. Health-seeking from the private sector has overtaken government facilities since 2006 with antibiotics mainly originating from pharmacies and private hospitals. Adherence to WHO recommended antibiotics has reduced over time. Conclusions: With rising wealth, there has been a decline in disease prevalence but an increase in antibiotic use with more access to unregulated sources. Understanding antibiotic use and identifying associated behavioural and socio-economic factors may help to inform interventions to reduce inappropriate antibiotic use whilst ensuring access to those who need them.

10 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
TWTianyi Wang
Tianyi Wang
MCMandy Che
Mandy Che
YHYash Huilgol
Yash Huilgol
HKHolly Keane
Holly Keane
DGDeborah Goodman
Deborah Goodman
LELaura Esserman
Laura Esserman
We performed a 318-participant validation study of an individualized risk assessment tool in women identified as having high- or highest-risk of breast cancer in the personalized arm of the Women Informed to Screen Depending on Measures of risk (WISDOM) trial. Per protocol, these women were educated about their risk and risk reducing options using the Breast Health Decisions (BHD) tool, which uses patient-friendly visuals and 8th grade reading level language to convey risk and prevention options. Prior to exposure to the educational tool, 4.7% of women were already taking endocrine risk reduction, 38.7% were reducing alcohol intake, and 62.6% were exercising. Three months after initial use of BHD, 8.4% of women who considered endocrine risk reduction, 33% of women who considered alcohol reduction, and 46% of women who considered exercise pursued the risk-reducing activities. Unlike lifestyle interventions which are under the control of the patient, additional barriers at the level of the healthcare provider may be impeding the targeted use of endocrine risk reduction medications in women with elevated breast cancer risk.

21 July 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
TWTianyi Wang
Tianyi Wang
ELEvan Luff
Evan Luff
TBTanima Basu
Tanima Basu
MTMichael P. Thompson
Michael P. Thompson
MNMark W. Newman
Mark W. Newman
JGJessica R. Golbus
Jessica R. Golbus